Pharmaceutical advertising in Hong Kong is subject to strict legal controls, primarily under the Undesirable Medical Advertisements Ordinance. First, advertisements to the public for medicines claiming to treat or prevent diseases or conditions listed in Schedule 1 to that Ordinance, such as cancer and diabetes, are prohibited. Second, advertisements that may lead or induce someone to use a medicine to terminate a pregnancy are prohibited. In addition, pharmaceutical advertisements must not contain false, exaggerated or misleading information. This covers advertisements in traditional media as well as on the internet and social media platforms.
HONG KONG DRUG LICENSING
What are the requirements for advertising medicines in Hong Kong, and what constitutes a breach?
A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.
Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.
Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions